


Healthcare News Roundup: DIagnostics
HSMN NewsFeed - 25 May 2016
Inivata Boosts Executive Team With Appointment of Clive Morris as Chief Medical Officer
Inivata Boosts Executive Team With Appointment of Clive Morris as Chief Medical Officer
HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
HSMN NewsFeed - 23 May 2016
Interpace Diagnostics Presents New Clinical Utility Data at Digestive Disease Week
Interpace Diagnostics Presents New Clinical Utility Data at Digestive Disease Week
HSMN NewsFeed - 19 May 2016
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
HSMN NewsFeed - 16 May 2016
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
HSMN NewsFeed - 9 May 2016
Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer
Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer
HSMN NewsFeed - 26 Apr 2016
Intuity Medical Receives FDA Clearance to Market POGO(R) Automatic(TM) Blood Glucose Monitoring System
Intuity Medical Receives FDA Clearance to Market POGO(R) Automatic(TM) Blood Glucose Monitoring System
HSMN NewsFeed - 21 Apr 2016
Abbott Introduces New Services and Tools to Help Labs Deliver Greater Operational Productivity
Abbott Introduces New Services and Tools to Help Labs Deliver Greater Operational Productivity
HSMN NewsFeed - 18 Apr 2016
Interpace Diagnostics Announces New Coding by Novitas Solutions for PancraGen(TM)
Interpace Diagnostics Announces New Coding by Novitas Solutions for PancraGen(TM)
HSMN NewsFeed - 7 Apr 2016
VolitionRx Announces CE Marks for Two NuQ(R) Blood Assays for Detection of Colorectal Cancer
VolitionRx Announces CE Marks for Two NuQ(R) Blood Assays for Detection of Colorectal Cancer
HSMN NewsFeed - 6 Apr 2016
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
